Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

BACKGROUND: This research aims to explore and compare the signals of rhabdomyolysis from the use of Proton pump inhibitors (PPIs) using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. METHODS: Rhabdomyolysis and related terms submitted between 2013 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Altebainawi, Ali F., Alfaraj, Lulwa A., Alharbi, Amjad A., Alkhuraisi, Fadwa F., Alshammari, Thamir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974623/
https://www.ncbi.nlm.nih.gov/pubmed/36875514
http://dx.doi.org/10.1177/20420986231154075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974623/
https://www.ncbi.nlm.nih.gov/pubmed/36875514
http://dx.doi.org/10.1177/20420986231154075

Ejemplares similares